SCHEMBL470230

SCHEMBL470230

COc1ccccc1-c1noc(C)c1C(=O)N1CCN(c2cc(N)c(Cl)cc2C)CC1

nearest known ligand 0.70

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.70
MAPK1 P28482 1/20 0.70
LMNA P02545 7/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
ALDH1A1 P00352 6/20 0.59
KDM4E B2RXH2 3/20 0.59
GAA P10253 1/20 0.59
HTT P42858 2/20 0.56
KMT2A Q03164 3/20 0.52
EPAS1 Q99814 1/20 0.52
MEN1 O00255 2/20 0.50
HIF1A Q16665 1/20 0.50
MAPT P10636 1/20 0.49
NPC1 O15118 1/20 0.49
TP53 P04637 1/20 0.48
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL470201 0.94 TSHR (0.71) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL459690 0.93 TSHR (0.70) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL12273645 0.90 TSHR (0.66) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL12457361 0.89 TSHR (0.65) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL10087679 0.89 TSHR (0.69) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL12273583 0.88 TSHR (0.65) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL470370 0.87 TSHR (0.66) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL456716 0.87 TSHR (0.66) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL470168 0.86 TSHR (0.65) TSHRMAPK1LMNASMN1; SMN2ALDH1A1
SCHEMBL457381 0.85 TSHR (0.64) TSHRMAPK1LMNASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012033736-A1 NOVEL PIPERAZINE ANALOGS AS BROAD-SPECTRUM INFLUENZA ANTIVIRALS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-15 WO disclosed